Sunshine Biopharma Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Sunshine Biopharma Inc. reported Cash And Cash Equivalents At Carrying Value of $21.83 million for the year ending 2022.

  • Sunshine Biopharma Inc. showed an increase of +967.2% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Sunshine Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on April 4, 2023.
  • XBRL data for this metric is available from 2010 to 2022 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2010 to 2022), Sunshine Biopharma Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 13,340.7%.
  • Historical annual values: Fiscal year 2022: $21.83 million | Fiscal year 2021: $2.05 million | Fiscal year 2020: $989.9 thousand | Fiscal year 2019: $40.5 thousand | Fiscal year 2018: $110.5 thousand | Fiscal year 2017: $107.5 thousand | Fiscal year 2016: $57.5 thousand | Fiscal year 2015: $50.8 thousand | Fiscal year 2014: $143.4 thousand | Fiscal year 2013: $31.2 thousand | Fiscal year 2012: $132.6 thousand | Fiscal year 2011: $60.7 thousand | Fiscal year 2010: $162.4 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: